Previous Article | Next Article 
Journal of Clinical Microbiology, November 1998, p. 3291-3296, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Extraintestinal Salmonellosis in a General Hospital (1991 to
1996): Relationships between Salmonella Genomic Groups
and Clinical Presentations
Mercedes
Rodríguez,1,2
Isabel
de Diego,1 and
M. Carmen
Mendoza2,*
Servicio de Microbiología, Hospital
Central de Asturias,1 and
Area de
Microbiología, Departamento de Biología Funcional,
Universidad de Oviedo,2 33006 Oviedo, Spain
Received 26 May 1998/Returned for modification 7 July 1998/Accepted 28 July 1998
 |
ABSTRACT |
Episodes of extraintestinal salmonellosis treated at a
general hospital (1,522 beds) over a 6-year period (1991 to 1996)
were characterized by the analysis of phenotypic and genotypic traits of Salmonella organisms and clinical data from
medical reports. Extraintestinal salmonellosis accounted for 8% of all
salmonellosis episodes. Fifty-two medical reports, dealing with 6 cases
of typhoid fever, 32 cases of bacteremia, and 14 focal infections, were
reviewed. All cases of typhoid fever except 1, 7 cases of bacteremia,
and 5 focal infections were not related to any underlying disease or
predisposing factors, while 25 cases of bacteremia and 9 focal infections were associated with some of these risk factors.
All typhoid isolates and 65.4% of the nontyphoid isolates were
susceptible to antimicrobials. Fifty-one nontyphoid strains were
analyzed and assigned to 21 genomic groups, which were defined
by serotype, combined ribotype, and combined randomly amplified
polymorphic DNA type (each genomic group could
include organisms differing in some phenotypic traits). The
relationships between genomic groups and clinical
presentations were traced. Organisms causing 22 episodes (17 episodes
of bacteremia, 2 of pneumonia, 1 of peritonitis, 1 of pyelonephritis,
and 1 of cystitis) belonged to a prevalent Salmonella
enterica serotype Enteritidis genomic group,
which included organisms assigned to four phage types, five biotypes, and four resistance patterns, causing infections in patients with and without risk factors. Seven other genomic groups, 4 Enteritidis groups (associated with both bacteremia and focal
infections), 2 Typhimurium groups (one associated with
bacteremia and the other with focal infections) and 1 Brandenburg group
(associated with bacteremia) included two or more strains, and the
remaining 13 genomic groups consisted of only one strain each.
 |
INTRODUCTION |
Despite improvements in individual
and collective sanitation as well as in the careful monitoring of food
processing, both sporadic episodes and outbreaks of salmonellosis
continue to occur with high frequency in industrial countries. Factors
such as intensive pig and poultry production are contributing to the
emergence of new clones of Salmonella pathogenic to humans.
Others, such as the increase in international travel, the rapidly
growing international food trade between countries with different
levels of hygiene in the production and manufacture of foods and with
different endemic pathogenic clones, are the cause of their dispersion
among different geographic areas. On the other hand, the increase in patients with AIDS, other immunodeficiencies, and chronic disorders, are factors that contribute to putting new groups of people at increased risk of developing severe clinical forms of salmonellosis.
Salmonella is an enteroinvasive bacterium and causes
infections that may have one of five different clinical presentations (4, 8). Gastroenteritis is the most common presentation in
industrial countries and is considered as an emergent food-borne pathogen-caused disease. It is a self-limited illness of brief duration, usually characterized by diarrhea and fever, in which antibiotic treatment is rarely indicated for immunocompetent patients. Much less frequent but much more severe presentations, usually requiring antibiotic treatment, are bacteremia-septicemia without localized infection and focal infections. Focal infections may affect
different sites in the body, causing different disorders, which
frequently occur during or after Salmonella bacteremia but may also occur concomitantly with other syndromes. These three clinical
presentations may be caused by many Salmonella serotypes considered zoonotic. Although any serotype can cause any of these presentations, certain serotypes have been associated with
specific presentations, e.g., Salmonella enterica serotype
Enteritidis and serotype Typhimurium are associated with
gastroenteritis, while serotype Choleraesuis and serotype Dublin are
associated with bacteremia (8, 23). Enteric fever, or
typhoid fever, is due to serotype Typhi (which is adapted to human
hosts; animals do not serve as a reservoir) but may also be caused by
other serotypes (mainly Paratyphi A, B, and C), and antibiotic
therapy clearly shortens the duration of the disease. Drinking
water disinfection and other sanitation measures have lowered its
frequency in industrial countries, but the frequency of this disease
remains very high in developing countries (8). A fifth
presentation is the chronic carrier state (enteric or urinary), defined
as the excretion of salmonellas for months or years after the initial
onset of disease, which is most frequent after Typhi infection.
The aim of this study was to carry out an evaluation of extraintestinal
salmonellosis cases treated in the Hospital Central de Asturias
(HCA), Oviedo, Spain, over a 6-year period (1991 to 1996). It was
conducted by analyzing the phenotypic and genotypic traits of
Salmonella organisms, clinical and other features of the
patients, and the relationships between nontyphoid
Salmonella genomic groups and clinical
presentations.
 |
MATERIALS AND METHODS |
Samples processed and Salmonella
characterization.
Blood and other clinical samples from patients
with clinically suspected bacteremia and focal infection were processed
according to standard techniques (2, 24). The microorganisms
from positive cultures were isolated and characterized by standard
laboratory methods. The biochemical profile (biotype) was ascertained
by the PASCO system (Difco). Serotyping was performed with
Bacto-Salmonella antisera for serotypes Enteritidis and
Typhimurium (Difco). Assignment to other serotypes, as well as phage
typing of Typhimurium and Enteritidis strains was carried out in the
Centro Nacional de Microbiología (CNM), Majadahonda, Madrid,
Spain, by using established phage-typing systems (1, 25).
Antimicrobial susceptibility test.
Antimicrobial
susceptibility testing was performed according to the guidelines of the
National Committee for Clinical Laboratory Standards for the
microdilution susceptibility test (17a) by using the
commercial antibiotic panel for Spain of the PASCO system (Difco),
which includes ampicillin, ampicillin-sulbactam, aztreonam, cefazolin,
cefotaxime, cefoxitin, ceftizoxime, ceftriaxone, cefuroxime, imipenem, piperacillin, ticarcillin, chloramphenicol,
gentamicin, tobramycin, amikacin, ciprofloxacin, ofloxacin, nalidixic
acid, fosfomycin, and trimethoprim-sulfamethoxazole. In addition,
streptomycin and sulfadiazine were analyzed by the disk diffusion
technique with commercial disks (Difco).
Genetic typing procedures.
Chromosomal DNA isolation and
ribotyping were conducted as described in references
10, 11, and 17
by using a DNA fragment carrying the rrnB operon of
Escherichia coli as a probe. Hybridization was
performed by using the nonradioactive DNA Labelling and Detection Kit
of Boehringer GmbH (Mannheim, Germany) according to the manufacturer's instructions. The different patterns of bands containing all or part of
the rRNA genes and flanking sequences (ribotypes) were designated with
the first letter (or letters) of the serotype, followed by the first
letter(s) of the restriction endonuclease(s) used (H for
HincII and PS for the mixture of PstI and
SphI) and a number assigned according to the order of
detection in our laboratories.
Randomly amplified polymorphic DNA analysis, or RAPD typing, was
carried out under the conditions previously described for each of the
primers used, OPB-17 (5'AGGGAACGAG) (15) and
Universal (5'TCACGATGCA) (27). Minor differences
in band intensity, as well as the weak bands, were not considered to
define RAPD types, which, in this work, were designated with the first
letter of the serotype, followed by the first letter of the primer used (O for OPB-17 and U for Universal) and a number assigned according to
the order of detection in our laboratories.
Typhimurium ATCC 14028 and Enteritidis ATCC 13076 were used as control
strains in all ribotyping and RAPD typing assays.
Data from medical reports.
Data obtained from the medical
reports of patients included age, sex, underlying diseases, portal of
entry, predisposing factors, fever, diarrhea, and leukocytosis, or
leukopenia, which were categorized according to standard criteria
(9, 16). Only two patients were hospitalized simultaneously,
but they were in different hospital buildings. During the period 1991 to 1996 there was no suspicion of Salmonella hospital
outbreaks, and no investigation into common vehicles of infection or
other possible linkages among the patients was recorded.
 |
RESULTS |
Microbiological data on extraintestinal salmonellosis.
During 1991 to 1996 in the HCA Microbiology Laboratories, a
total of 970 Salmonella isolates were collected, 890 from
feces (92%), 59 from blood (6%), and 21 from other clinical samples (2%). These isolates represented 57, 1.3, and 0.025% of bacteria collected from feces, blood, and other clinical samples, respectively. Eighty samples other than feces, from 68 patients, were registered as
positive for Salmonella. All but one of the isolates
belonged to subspecies 1 and were differentiated into three serogroups (B, C, and D) which included seven serotypes (Typhimurium, Brandenburg, Bredeney, and Derby in serogroup B, Hadar in serogroup C, and Enteritidis and Typhi in serogroup D). No Typhi or Derby organisms were
available for further testing, but some data from these organisms were
compiled from microbiological reports. Enteritidis and Typhimurium strains were the most frequent; they were isolated from different types
of clinical samples and were associated with different clinical presentations (Table 1).
The nontyphoid isolates were characterized by different phenotypic and
genotypic procedures. Isolates from a single patient collected from
different samples and showing identical traits were assigned to the
same strain. In total, 51 strains were differentiated (Table 1). The
phenotypic traits analyzed were the biochemical profile (biotype) and
resistance to antimicrobial agents (R pattern) (for all isolates) and
the phage type (for Typhimurium and Enteritidis only). The most
frequent biotype was BT1 (59%), characterized by fermenting glucose,
mannose, saccharose, arabinose, trehalose, sorbitol, melibiose, and
rhamnose, producing decarboxylation of lysine and ornithine, using
citrate as a carbon source, and growing in the presence of penicillin.
The second most frequent was BT2 (8%), differing from BT1 in that it
did not ferment saccharose. All Typhi strains had been assigned to
BT14, characterized by low biochemical activity (not fermenting
arabinose and rhamnose, not producing ornithine decarboxylase, and not
using citrate or growing in penicillin).
Thirty-three nontyphoid strains (65%) were susceptible to all
antimicrobials tested; the remaining strains were grouped into seven R
patterns. The three most frequent R patterns consisted of
resistance to only one drug, ampicillin (18%), cotrimoxazole (6%), or chloramphenicol (4%), and only four strains (8%)
showed resistance to two or more drugs (for this purpose the
trimethoprim-sulfamethoxazole combination was considered a single drug,
named cotrimoxazole). The percentage of resistant isolates varied among
serotypes; while 57% of Typhimurium isolates were resistant to
some antimicrobial, only 33% of Enteritidis isolates had this
characteristic. The most frequent resistance was to ampicillin
(25.5%), followed by resistance to chloramphenicol (10%) and
cotrimoxazole (8%), which are antibiotics used in the control of
extraintestinal salmonellosis. All strains were susceptible to
quinolones and expanded-spectrum cephalosporins. The six Typhi
strains had been reported to be susceptible to all antimicrobials.
Phage typing of Enteritidis revealed the existence of a prevalent
phage type, PT4 (61.5%); the second and third most frequent phage types were PT6a (15.4%) and PT6 (10.2%), respectively.
All PT6 and PT6a strains were resistant to ampicillin (one was also resistant to chloramphenicol), while all PT4 strains but one were susceptible to all drugs tested. The Typhimurium organisms
were assigned to two phage types, DT23 and DT193, but five
strains were nontypeable (71.5%). No association between phage type
and drug resistance was observed.
By ribotyping performed with HincII, the nontyphoid isolates
were grouped into 9 H ribotypes, and by ribotyping with the
PstI-SphI mixture, they were grouped into 15 PS
ribotypes (Fig. 1). It is significant
that no ribotype included strains of different serotypes and that,
while isolates of Enteritidis and Typhimurium were differentiated by
both ribotyping procedures, different numbers of types and different
distributions of strains into types were found with the two procedures
(Table 1). Enteritidis isolates were differentiated into two H
ribotypes and nine PS ribotypes (ATCC 13076 showed E-H1 and E-PS3
ribotypes), while Typhimurium strains were differentiated into three H
ribotypes and two PS ribotypes (ATCC 14028 showed T-H12 and T-PS3
ribotypes).

View larger version (100K):
[in this window]
[in a new window]
|
FIG. 1.
Ribotypes found in Salmonella strains causing
extraintestinal diseases. ST, serotype; E, Enteritidis; T, Typhimurium;
B, Brandenburg; H, Hadar; S, Subspecies III; Br, Bredeney. RT,
ribotype; the arabic numeral corresponds to the order assigned to the
ribotype in our laboratories. a, ATCC 13076; b,
ATCC 14028. (a) H ribotypes generated by HincII. , lambda
DNA cleaved with PstI; sizes of fragments (in kilobases)
from top to bottom are 5.08, 4.65, 4.5, 2.84, 2.58, 2.14, 1.98, 1.2, 1.1, 0.8, 0.5, and 0.2. (b) PS ribotypes generated by a mixture of
PstI and SphI. , lambda DNA cleaved with
HindIII; sizes of fragments (in kilobases) from top to
bottom are 27.5, 23.1, 9.4, 6.55, 4.36, and 2.32.
|
|
By RAPD typing using the primers OPB-17 and Universal, the series was
differentiated into seven RAPD types with each primer, and strains of
different serotypes presented different RAPD types with both
primers (Fig. 2). Enteritidis strains
were differentiated into two RAPD types with OPB-17 but showed a
single type with Universal (ATCC 13076 exhibited types E-O2 and E-U1),
while Typhimurium strains showed a single type with OPB-17 and two
types with Universal (ATCC 14028 showed types T-O1 and T-U1).

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 2.
RAPD types of Salmonella strains causing
extraintestinal diseases, obtained by using the primers labelled OPB-17
and Universal. ST, serotype; E, Enteritidis; T, Typhimurium; B,
Brandenburg; H, Hadar; S, Subspecies III; Br, Bredeney. AT, amplified
type; the arabic numeral corresponds to the order assigned to the RAPD
type in our laboratories. a, ATCC 13076; b,
ATCC 14028. , lambda DNA cleaved with PstI; sizes of
fragments (in kilobases) from top to bottom are 5.08, 2.8, 2.1, 1.7, 1.15, 1.1, 0.8, 0.5, and 0.4.
|
|
In this work it was considered appropriate to use the data from
serotyping and typing methods analyzing DNA traits (ribotyping and RAPD typing) to define genomic groups, and then to
incorporate phenotypic traits (biotype, phage type, and R pattern) in
order to differentiate clones. According to these criteria, nontyphoid Salmonella isolates were assigned to 21 genomic
groups, of which 12 included only Enteritidis strains and 5 included
only Typhimurium strains (Table 1). The presence of a prevalent
genomic group (genomic group I [GG I], characterized
by serotype Enteritidis, ribotypes E-H1 and E-PS1, and RAPD types E-O1
and E-U1) which included nine different clones can be emphasized. The
most frequent clone (BT1, PT4, drug susceptible) included organisms to
which 13 apparently unrelated episodes (given that the patients
affected were hospitalized at different times and in some cases were in hospital wards situated in different buildings and were attended by
different personnel) were attributed.
Patient data associated with extraintestinal salmonellosis.
The medical and microbiological reports of only 52 patients with
extraintestinal salmonellosis were available for review; it was found
that 6 episodes had been diagnosed as typhoid fever, 32 as bacteremia,
and 14 as focal infections (5 in the urinary tract, four
pleuropulmonary, three abdominal, one in the central nervous system,
and one osteoarticular). The most relevant epidemiological and clinical
features of the three groups of clinical presentations are summarized
in Table 2, and some of these features
are discussed here. Typhoid fever and urinary-tract infections were
more frequent in females than in males (2:1 and 4:1, respectively),
whereas bacteremia and nonurinary focal infections were more frequent in males than in females (2.2:1 and 3:1, respectively). In relation to
age groups, all but one of the patients with typhoid fever were under
31 years of age without predisposing conditions. Two of the
episodes in the pediatric age group were diagnosed as bacteremia, affecting an 8-month-old boy and an 11-month-old girl, both
of whom had no underlying disease but had presented with diarrhea previously. Thirteen bacteremia episodes and one urinary-tract infection affected young adults (20 to 45 years of age), of whom seven
had AIDS, one had neoplasia, one had diabetes, one had undergone gastrectomy, and the remaining four had no predisposing conditions but
had suffered diarrhea previously. Fifteen cases of bacteremia (46.8%)
and 11 focal infections (78.6%) corresponded to the geriatric group
(over 61), of whom eight had diabetes.
Regarding clinical presentation and prognosis, bacteremia and focal
infections were more frequent among patients with some underlying
disease (78.2 and 64.3%, respectively). However, five of six (83.3%)
cases of typhoid fever occurred in patients without underlying disease,
and the sixth patient had a nonfatal disease (hiatal hernia). The
spectrum of underlying diseases covered a wide range of disorders, but
only one was categorized as rapidly fatal: acute leukemia associated
with bacteremia and previous gastroenteritis. Twelve patients with
bacteremia, two patients with pulmonary infections, and one patient
with a urinary infection had ultimately fatal underlying diseases. Of
these, seven bacteremia patients and the two patients with pulmonary
infections died. The remaining 18 episodes were categorized as having
nonfatal prognoses, but three of these patients died. These were three males over the age of 65, of whom two had diabetes and one had undergone gastrectomy. No underlying disease was recorded for seven
patients with bacteremia and five with focal infections; none of these
patients died.
 |
DISCUSSION |
HCA is a general hospital incorporating the former Hospital
Covadonga of Oviedo and Hospital General of Asturias, with 1,522 beds
and 80% bed occupancy; it serves a population of about 200,000 inhabitants and is the reference center for other hospitals in the
Principality of Asturias. In the HCA the overall incidence of
bloodstream invasion by nontyphoid salmonellas over the period 1991 to
1996 was 7.63%. The percent Salmonella-positive
hemocultures was 1.3%, lower than the percentage reported in the
previous decade (24) despite the increase in patients with
AIDS and other immunodeficiencies. This is similar to the percentage
reported by the Spanish Bacteremia Group (1.58%), which compiled data
from six Spanish hospitals (9).
From the present study, three microbiological findings should
be discussed. Firstly, in the HCA, over the period 1991 to 1996, the serotypes most frequently recorded as causing human salmonellosis were Enteritidis, Typhimurium, Virchow, and Hadar, with 534, 254, 28, and 8 isolates, respectively; no isolate was identified as Choleraesuis
or Dublin. Enteritidis and Typhimurium isolates were also the most
frequent causes of extraintestinal salmonellosis treated in the HCA,
whereas no episodes attributable to Virchow and only one attributable
to Hadar were recorded. These data are in line with those recorded in
other Spanish hospitals (3, 18) but differ from those of
studies in other countries, in which Choleraesuis (21),
Dublin (14), and Virchow (26) were reported as
the most frequent causes of bacteremia. A review of Salmonella bacteremia in England and Wales (23)
reported that less than 2% of nontyphoid salmonellas
isolated from humans were from blood culture and emphasized that while
the greatest number of bloodstream isolates were Enteritidis
and Typhimurium, the highest incidence of septicemias was attributable
to Choleraesuis, Dublin, and Virchow. Secondly, the most frequent
genomic group (Enteritidis GG I) causing extraintestinal
infections was also the most frequent group associated with intestinal
infections. It could be considered endemic in Spain because it has been
circulating over the last decade, mainly associated with poultry and
hen eggs as the infection vehicles (references 11
and 12 and unpublished data). Thirdly, 35% of the
Salmonella isolates were resistant to one (ampicillin,
cotrimoxazole, or chloramphenicol) or more (ampicillin and
chloramphenicol; ampicillin, chloramphenicol, and cotrimoxazole; or
ampicillin and cefonicid) antimicrobial drugs used in salmonellosis
control; the rate of resistance to these was similar to the rate
reported in other Spanish series (6, 19) but higher than
that reported in the United States (13). Not all serotypes
had similar frequencies of resistance, and the high percentage of
multidrug-resistant Typhimurium isolates is in line with data from
other works (5). Another interesting finding is the
association of Enteritidis PT6 and PT6a with resistance to
ampicillin (78% of the strains tested in our laboratories). These
strains carried a 25-MDa plasmid and fell into
different genomic groups, while no PT4 strain
showed this resistance or carried 25-MDa plasmids.
Regarding the features of the patients with Salmonella
bacteremia, the following observations could be noteworthy. (i)
Bacteremia was recorded for all age groups but did not show the bimodal
distribution, with a higher incidence at the two extremes, which
is usually reported (3, 20), although the geriatric
group showed the highest frequency (14 patients, most of whom
had predisposing factors). The strains collected from geriatric
patients belonged to seven genomic groups; one, GG I
(Enteritidis), was implicated in eight episodes, and each of the
other six groups was implicated in one episode. (ii) Six of the eight
patients between 21 and 31 years of age had AIDS. Only salmonellas
from four AIDS patients could be characterized, and these were assigned
to three genomic groups: two Enteritidis groups (GG I and GG X)
and one Typhimurium group (GG XIII). It has been reported that
bacteremia is about 100 times more frequent in AIDS patients than in
the general population (22). (iii) The most frequent
bacterial portal of entry was the gastrointestinal tract (56% of the
patients), and presumably most of the remaining patients (44%) could
also have been infected by this route. It is also noteworthy that a
high percentage of patients (72%) had predisposing factors that could
have favored the development of blood infection; other authors report
lower percentages, ranging from 27 to 62% (14, 18, 26).
With respect to focal infections, we found that those affecting the
urinary tract were the most frequent, including five episodes caused by strains assigned to four genomic groups, three
Enteritidis groups (GG I, II, and IX) and one Typhimurium group
(GG XIV). The single pyelonephritis episode was caused by one
Enteritidis GG I strain in an AIDS patient (a 27-year-old male) with
previous and recurrent Salmonella bacteremia. In other
reports (7), the most frequent Salmonella focal
infections were osteoarticular, while in our series only one patient (a
63-year-old male with diabetes) had a lumbar spondylodiskitis caused by
an Enteritidis GG II strain. The four patients with pulmonary infection
had illnesses predisposing them to infection; two of these
had malignancies. Symptoms and signs were typical of patients
presenting with acute bacterial pneumonia, and two patients had
Salmonella-positive blood cultures, which supported
hematogenous dissemination; these data are in line with the review
described in reference 4. Three episodes were caused
by Enteritidis (GG I and GG IV), and the fourth was caused by a
Typhimurium GG XV strain resistant to ampicillin, cotrimoxazole,
chloramphenicol, and streptomycin.
Salmonella meningitis is frequently reported in
children, while it is seldom described in adults and AIDS
patients. The only episode in our series affected a 65-year-old female
without predisposing illness and without a previous episode of
gastroenteritis; it was caused by an Enteritidis GG XII strain.
Finally, the only three episodes classified as intra-abdominal
infections (one case of peritonitis, one of perirectal abscesses, and
one of cholecystitis) were caused by three very different strains
(Enteritidis GG I, Typhimurium GG XV, and Subspecies IIIb GG XXI,
respectively). Infections directly related to the digestive tract had a
pathologic significance different from that of the other focal
infections by Salmonella and did not indicate severe
immunosuppression.
In conclusion, this study revealed that extraintestinal salmonellosis
more frequently affected patients with some predisposing factor
and/or underlying disease than patients without these features (2:1 ratio). Furthermore, it was caused by genotypically and
phenotypically heterogeneous Salmonella organisms, although
many of these (43.1%) belong to a prevalent genomic
group of Enteritidis. Organisms assigned to this group have
also been found frequently in human feces, food samples, and water
samples collected over the last decade in different Spanish regions and
are considered prevalent and endemic in Spain (11, 12).
 |
ACKNOWLEDGMENTS |
We thank M. A. Usera and CNM for the phage typing of
the Enteritidis and Typhimurium strains and F. Pérez for
the Salmonella isolates.
This work was supported by grants from the Fondo de Investigación
Sanitaria (Ref. 95/0030-01 and 98/0296).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Area
Microbiología, Facultad de Medicina, C/Julián
Clavería s/n, 33006 Oviedo, Spain. Phone: 34 985103148. Fax: 34 985103148. E-mail:
camf{at}sauron.quimica.uniovi.es.
 |
REFERENCES |
| 1.
|
Anderson, E. S.,
L. R. Ward,
M. J. de Saxe, and J. D. H. de Sa.
1977.
Bacteriophage-typing designations of Salmonella typhimurium.
J. Hyg.
78:297-300.
|
| 2.
|
Balows, A.,
W. J. Hausler, Jr.,
K. L. Herrmann,
H. D. Isenberg, and H. J. Shadomy (ed.).
1991.
Manual of clinical microbiology, 5th ed.
American Society for Microbiology, Washington, D.C.
|
| 3.
|
Bassa, A.,
F. Parras,
J. Reina,
E. Villar,
J. Gil, and P. Alomar.
1989.
Non-Typhi Salmonella bacteraemia.
Infection
17:290-293[Medline].
|
| 4.
|
Cohen, J. I.,
J. A. Bartlett, and G. Ralph Corey.
1987.
Extra-intestinal manifestations of Salmonella infections.
Medicine
66:349-387[Medline].
|
| 5.
|
Cohen, M., and R. Tauxe.
1986.
Drug-resistant Salmonella in the United States: an epidemiologic perspective.
Science
234:964-969[Abstract/Free Full Text].
|
| 6.
|
Galán, J. C.,
M. Varea,
F. J. Castillo,
A. Clavel, and R. Gómez-Lus.
1996.
Resistencia antibiótica en Salmonella entérica: un problema en aumento.
Enferm. Infecc. Microbiol. Clin.
14:528-532[Medline].
|
| 7.
|
García-Rodríguez, J. A.,
J. E. García-Sánchez,
J. L. Muñoz-Bellido, and M. I. García-García.
1990.
Salmonellosis focal en España. Analisis de 14 casos y revisión de la literatura.
Enferm. Infecc. Microbiol. Clin.
8:134-142[Medline].
|
| 8.
|
Goldberg, M. B., and R. H. Rubin.
1988.
The spectrum of Salmonella infection.
Infect. Dis. Clin. N. Am.
2:571-598[Medline].
|
| 9.
|
Grupo de estudio de la bacteriemia.
1986.
Bacteriemia en seis hospitales españoles.
Med. Clín.
86:221-232.
|
| 10.
|
Guerra, B.,
E. Landeras,
M. A. Gonzalez-Hevia, and M. C. Mendoza.
1997.
A three-way ribotyping scheme for Salmonella serotype Typhimurium and its usefulness for phylogenetic and epidemiological purposes.
J. Med. Microbiol.
46:307-313[Abstract].
|
| 11.
|
Landeras, E., and M. C. Mendoza.
1998.
Evaluation of PCR-based typing methods and ribotyping performed with a mixture of PstI and SphI to differentiate strains of Salmonella enterica serotype Enteritidis.
J. Med. Microbiol.
47:427-434[Abstract].
|
| 12.
|
Landeras, E.,
M. A. Gonzalez-Hevia, and M. C. Mendoza.
1998.
Molecular epidemiology of Salmonella serotype Enteritidis.
Relationships between food, environmental and clinical strains. Int. J. Food Microbiol., in press.
|
| 13.
|
Lee, L. A.,
N. D. Puhr,
E. K. Maloney,
N. H. Bean, and R. V. Tauxe.
1994.
Increase in antimicrobial resistant Salmonella infections in the United States, 1989-90.
J. Infect. Dis.
170:128-134[Medline].
|
| 14.
|
Lester, A.,
N. H. Eriksen,
P. B. Nielsen,
A. Friis-Moller,
B. Bruun,
J. Scheibel,
K. Gaarslev, and H. J. Kolmos.
1991.
Non-typhoid Salmonella bacteraemia in Greater Copenhagen 1984 to 1988.
Eur. J. Clin. Microbiol. Infect. Dis.
10:486-490[Medline].
|
| 15.
|
Lin, A. W.,
M. A. Usera,
T. J. Barrett, and R. A. Goldsby.
1996.
Application of random amplified polymorphic DNA analysis to differentiate strains of Salmonella enteritidis.
J. Clin. Microbiol.
34:870-876[Abstract].
|
| 16.
|
McCabe, W. R., and G. G. Jackson.
1962.
Gram negative bacteremia. I. Etiology and ecology.
Arch. Intern. Med.
110:847-855.
|
| 17.
|
Mendoza, M. C.,
R. Alzugaray,
E. Landeras, and M. A. González-Hevia.
1996.
Discriminatory power and application of ribotyping of Yersinia enterocolitica O:3 in an epidemiological study.
Eur. J. Clin. Microbiol. Infect. Dis.
15:220-226[Medline].
|
| 17a.
|
National Committee for Clinical Laboratory Standards.
1993.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 18.
|
Ramos, J. M.,
P. García-Corbeira,
J. M. Aguado,
R. Arjona,
J. M. Alés, and F. Soriano.
1994.
Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS.
Clin. Infect. Dis.
19:777-780[Medline].
|
| 19.
|
Reina, J.,
J. Gómez,
A. Serra, and N. Borrell.
1993.
Analysis of the antibiotic resistance detected in 2,043 strains of S. enterica isolates in stool cultures of Spanish patients with acute diarrhoea (1981-1991).
J. Antimicrob. Chemother.
32:765-769[Free Full Text].
|
| 20.
|
Sai-Cheong, L.,
Y. Pun-Hung,
S. Wen-Ben, and R. Lassarre.
1994.
Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review.
Clin. Infect. Dis.
19:693-696[Medline].
|
| 21.
|
Saphra, I., and J. W. Winter.
1957.
Clinical manifestations of salmonellosis in man. An evaluation of 7,779 human infections identified at the New York Salmonella Center.
N. Engl. J. Med.
256:1128-1134.
|
| 22.
|
Sperber, S. J., and C. J. Schleupner.
1987.
Salmonellosis during infection with human immunodeficiency virus.
Rev. Infect. Dis.
9:925-933[Medline].
|
| 23.
|
Threlfall, E. J.,
M. L. M. Hall, and B. Rowe.
1992.
Salmonella bacteraemia in England and Wales, 1981-1990.
J. Clin. Pathol.
45:34-36[Abstract/Free Full Text].
|
| 24.
|
Vazquez, F.,
M. C. Mendoza,
M. H. Villar,
F. Pérez, and F. J. Méndez.
1994.
Survey of bacteraemia in a Spanish hospital over a decade (1981-1990).
J. Hosp. Infect.
26:111-121[Medline].
|
| 25.
|
Ward, L. R.,
J. D. H. de Sa, and B. Rowe.
1987.
A phage typing scheme for Salmonella enteritidis.
Epidemiol. Infect.
99:291-294[Medline].
|
| 26.
|
Wilkins, E. G. L., and C. Roberts.
1988.
Extraintestinal salmonellosis.
Epidemiol. Infect.
100:361-368[Medline].
|
| 27.
|
Williams, J. G. K.,
A. R. Kubelik,
K. J. Livak,
J. A. Rafalski, and S. V. Tingey.
1990.
DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.
Nucleic Acids Res.
18:6531-6535[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, November 1998, p. 3291-3296, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pust, S., Hochmann, H., Kaiser, E., von Figura, G., Heine, K., Aktories, K., Barth, H.
(2007). A Cell-permeable Fusion Toxin as a Tool to Study the Consequences of Actin-ADP-ribosylation Caused by the Salmonella enterica Virulence Factor SpvB in Intact Cells. J. Biol. Chem.
282: 10272-10282
[Abstract]
[Full Text]
-
Soto, S. M., Rodriguez, I., Rodicio, M. R., Vila, J., Mendoza, M. C.
(2006). Detection of virulence determinants in clinical strains of Salmonella enterica serovar Enteritidis and mapping on macrorestriction profiles.. J Med Microbiol
55: 365-373
[Abstract]
[Full Text]
-
Valle, E., Guiney, D. G.
(2005). Characterization of Salmonella-Induced Cell Death in Human Macrophage-Like THP-1 Cells. Infect. Immun.
73: 2835-2840
[Abstract]
[Full Text]
-
Can, F., Demirbilek, M., Erdem, B., Ciftci, U., Tunaoglu, M., Laleli, Y.
(2004). A purulent pericarditis caused by Salmonella typhimurium. J Med Microbiol
53: 1051-1052
[Abstract]
[Full Text]
-
Tezcan-Merdol, D., Ljungstrom, M., Winiecka-Krusnell, J., Linder, E., Engstrand, L., Rhen, M.
(2004). Uptake and Replication of Salmonella enterica in Acanthamoeba rhysodes. Appl. Environ. Microbiol.
70: 3706-3714
[Abstract]
[Full Text]
-
Bjorkman, P., Nilsson, A., Riesbeck, K.
(2002). A Pilot with Pain in His Leg: Thigh Abscess Caused by Salmonella enterica Serotype Brandenburg. J. Clin. Microbiol.
40: 3530-3531
[Abstract]
[Full Text]
-
Persson, K., Morgelin, M., Lindbom, L., Alm, P., Bjorck, L., Herwald, H.
(2000). Severe Lung Lesions Caused by Salmonella Are Prevented by Inhibition of the Contact System. J. Exp. Med.
192: 1415-1424
[Abstract]
[Full Text]